目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T27135 | Parasite | ||
DDD85646 是 T. brucei N-myristoyltransferase 的抑制剂,Ki 为 1.44 nM,IC50 为 2 nM,EC50 为 2 nM。 hNMT 的 IC50 为 4 nM。 | |||
T23973 | Others | ||
DDD100097 是一种有效的 N-肉豆蔻醇转移酶抑制剂,对布氏锥虫具有潜在的抑制作用,可用于研究神经系统疾病。 | |||
T3628 | DNA/RNA Synthesis | ||
Madrasin (DDD00107587) 是剪接抑制剂,在体外能够阻止剪接中间体和产物的形成,并干扰剪接体组装途径中的一个或多个早期步骤。它能在体外抑制 pre-mRNA 的剪接,并修饰细胞中内源性 pre-mRNA 的剪接。 | |||
T1199 | Apoptosis AChR | ||
Mitotane (NCI-C04933) 是 DDD 的同分异构体和 DDT 的衍生物,可作用于肾上腺皮质癌,有抗癌活性。 | |||
T20935 | |||
TDE is an organochlorine insecticide with slightly irritating to the skin. | |||
T33132 | |||
m,p'-DDD is a bioactive chemical. | |||
T15438 | Parasite | ||
GSK3186899 是 Cdc2 相关激酶 12 的抑制剂,对 L. donovani 的 EC50 为 1.4 μM。 | |||
T23971 | |||
DDD00079282 is an inhibitor of IMPDH. | |||
T23972 | |||
DDD-028 is a potential non-opioid and non-cannabinoid analgesic. It was used for treating neuropathic and inflammatory pain. | |||
T23970 | |||
DDD00015314 is the GUS reporter activity activator that acts by specifically increasing stumpy reporter gene expression. |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-04141 | Complement factor H/CFH Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 | ||
Complement factor H, also known as H factor 1, and CFH, is a sialic acid containing glycoprotein that plays an integral role in the regulation of the complement-mediated immune system that is involved in microbial defense, immune complex processing, and programmed cell death. Factor H protects host cells from injury resulting from unrestrained complement activation. CFH regulates complement activation on self cells by possessing both cofactor activity for the Factor I mediated C3b cleavage, and decay accelerating activity against the alternative pathway C3 convertase, C3bBb. CFH protects self cells from complement activation but not bacteria/viruses. Due to the central role that CFH plays in the regulation of complement, there are many clinical implications arrising from aberrant CFH activity. Mutations in the Factor H gene are associated with severe and diverse diseases including the rare renal disorders hemolytic uremic syndrome (HUS) and membranoproliferative glomerulonephritis (MPGN) also termed dense deposit disease (DDD), membranoproliferative glomuleronephritis type II or dense deposit disease, as well as the more frequent retinal disease age related macular degeneration (AMD). In addition to its complement regulatory activities, factor H has multiple physiological activities and 1) acts as an extracellular matrix component, 2) binds to cellular receptors of the integrin type, and 3) interacts with a wide selection of ligands, such as the C-reactive protein, thrombospondin, bone sialoprotein, osteopontin, and heparin.
|
|||||
TMPY-04129 | Complement factor H/CFH Protein, Mouse, Recombinant (His) | Mouse | HEK293 | ||
Complement factor H, also known as H factor 1, and CFH, is a sialic acid containing glycoprotein that plays an integral role in the regulation of the complement-mediated immune system that is involved in microbial defense, immune complex processing, and programmed cell death. Factor H protects host cells from injury resulting from unrestrained complement activation. CFH regulates complement activation on self cells by possessing both cofactor activity for the Factor I mediated C3b cleavage, and decay accelerating activity against the alternative pathway C3 convertase, C3bBb. CFH protects self cells from complement activation but not bacteria/viruses. Due to the central role that CFH plays in the regulation of complement, there are many clinical implications arrising from aberrant CFH activity. Mutations in the Factor H gene are associated with severe and diverse diseases including the rare renal disorders hemolytic uremic syndrome (HUS) and membranoproliferative glomerulonephritis (MPGN) also termed dense deposit disease (DDD), membranoproliferative glomuleronephritis type II or dense deposit disease, as well as the more frequent retinal disease age related macular degeneration (AMD). In addition to its complement regulatory activities, factor H has multiple physiological activities and 1) acts as an extracellular matrix component, 2) binds to cellular receptors of the integrin type, and 3) interacts with a wide selection of ligands, such as the C-reactive protein, thrombospondin, bone sialoprotein, osteopontin, and heparin.
|